Literature DB >> 16809607

Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003.

Ryan J Deibert1, Gary Goldbaum, Theodore R Parker, Holly Hagan, Robert Marks, Michael Hanrahan, Hanne Thiede.   

Abstract

We examined pharmacists' attitudes and practices related to syringe sales to injection drug users before and after legal reform and local programming to enhance sterile syringe access. We replicated a 1996 study by conducting pharmacist phone surveys and syringe test-buys in randomly selected pharmacies. Test-buy success increased from 48% in 1996 to 65% in 2003 (P=.04). Pharmacists agreeing that syringes should be available to injection drug users through pharmacy purchase increased from 49% to 71% (P<.01). Pharmacy policies and pharmacist attitudes were strongly associated with syringe access. Structural changes, including policy reform and pharmacy outreach, appear to increase syringe access. Interventions should address pharmacy policies and pharmacist attitudes and policies.

Keywords:  Empirical Approach; Health Care and Public Health

Mesh:

Substances:

Year:  2006        PMID: 16809607      PMCID: PMC1522120          DOI: 10.2105/AJPH.2003.032698

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  29 in total

1.  Changes in injection risk behavior associated with participation in the Seattle needle-exchange program.

Authors:  H Hagan; H Thiede
Journal:  J Urban Health       Date:  2000-09       Impact factor: 3.671

2.  The legality of selling or giving syringes to injection drug users.

Authors:  Scott Burris; Jon S Vernick; Alyssa Ditzler; Steffanie Strathdee
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

Review 3.  Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal.

Authors:  T Stephen Jones; Phillip O Coffin
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

4.  Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia.

Authors:  Jennifer Taussig; Benjamin Junge; Scott Burris; T Stephen Jones; Claire E Sterk
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

5.  Encouraging pharmacy sale and safe disposal of syringes in Seattle, Washington.

Authors:  Robert W Marks; Michael Hanrahan; Donald H Williams; Gary Goldbaum; Henne Thiede; Robert W Wood
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

6.  Increasing legal and regulatory support for pharmacy syringe sales to injection drug users, Washington State, 1999-2002.

Authors:  Donald H Williams
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Nov-Dec

7.  Impact of the change in Connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices.

Authors:  L Wright-De Agüero; B Weinstein; T S Jones; J Miles
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

8.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 9.  The role of needle exchange programs in HIV prevention.

Authors:  D Vlahov; B Junge
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.

Authors:  I van Beek; R Dwyer; G J Dore; K Luo; J M Kaldor
Journal:  BMJ       Date:  1998-08-15
View more
  14 in total

1.  Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.

Authors:  Alexandra Lutnick; Erin Cooper; Chaka Dodson; Ricky Bluthenthal; Alex H Kral
Journal:  J Urban Health       Date:  2013-04       Impact factor: 3.671

2.  Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.

Authors:  Thomas J Stopka; Alexandra Lutnick; Lynn D Wenger; Kathryn Deriemer; Estella M Geraghty; Alex H Kral
Journal:  Am J Epidemiol       Date:  2012-05-04       Impact factor: 4.897

3.  Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.

Authors:  Robin A Pollini
Journal:  J Am Pharm Assoc (2003)       Date:  2017-08-12

4.  Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015.

Authors:  Thomas J Stopka; Ashley Donahue; Marguerite Hutcheson; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-08

5.  Factors associated with presence of pharmacies and pharmacies that sell syringes over-the-counter in Los Angeles County.

Authors:  Thomas J Stopka; Estella M Geraghty; Rahman Azari; Ellen B Gold; Kathryn Deriemer
Journal:  J Urban Health       Date:  2013-12       Impact factor: 3.671

6.  Syringe access and health harms: Characterizing "landscapes of antagonism" in California's Central Valley.

Authors:  Jennifer L Syvertsen; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2019-11-24

7.  Naloxone Availability and Pharmacy Staff Knowledge of Standing Order for Naloxone in Pennsylvania Pharmacies.

Authors:  Rachel L Graves; Elena Andreyeva; Jeanmarie Perrone; Frances S Shofer; Raina M Merchant; Zachary F Meisel
Journal:  J Addict Med       Date:  2019 Jul/Aug       Impact factor: 3.702

8.  Nonprescription syringe sales: a missed opportunity for HIV prevention in California.

Authors:  Robin A Pollini; Abby E Rudolph; Patricia Case
Journal:  J Am Pharm Assoc (2003)       Date:  2015 Jan-Feb

9.  Barriers to pharmacy-based syringe purchase among injection drug users in Tijuana, Mexico: a mixed methods study.

Authors:  Robin A Pollini; Remedios Lozada; Manuel Gallardo; Perth Rosen; Alicia Vera; Armando Macias; Lawrence A Palinkas; Steffanie A Strathdee
Journal:  AIDS Behav       Date:  2010-06

10.  Estimated effect of US state syringe sale policy on source of last-used injection equipment.

Authors:  Patrick Janulis; Barrett W Montgomery; James C Anthony
Journal:  Int J Drug Policy       Date:  2019-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.